First Tracks Biotherapeutics

TRAXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.582 B

$45.33 +0.04%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

34,892,381

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#133Maravai LifesciencesMRVI$1.61B
#134Tyra BiosciencesTYRA$1.58B
#135First Tracks BiotherapeuticsTRAX$1.58B
#136Forte BiosciencesFBRX$1.57B
#137XencorXNCR$1.55B

Where these numbers come from

Share counts and financials for First Tracks Biotherapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.